ST-segment elevation during levosimendan infusion
Francesco Barillà1, Federica Giordano, Ilaria Jacomelli
1Department of Heart and Great Vessels 'Attilio Reale', La Sapienza University of Rome. francesco.barilla@uniroma1.it
Insights
Levosimendan enhances heart contractility but may cause myocardial ischemia in acute heart failure patients. This finding is crucial for managing heart failure safely.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Levosimendan is a calcium sensitizer used for acute decompensated severe congestive heart failure.
- It increases myocardial contractility through positive inotropic effects.
Observation:
- This study reports on the potential adverse effects of levosimendan infusion.
- Specifically, the induction of myocardial ischemia was observed.
Findings:
- Levosimendan infusion can precipitate myocardial ischemia in patients diagnosed with acute heart failure.
- This adverse effect was noted despite its therapeutic indications.
Implications:
- Clinicians should exercise caution when administering levosimendan to acute heart failure patients.
- Monitoring for signs of myocardial ischemia during levosimendan therapy is recommended.
Abstract:
Levosimendan increases the sensitivity of the heart to calcium and consequently exerts positive inotropic effects. Levosimendan is indicated in acutely decompensated severe congestive heart failure. We report that levosimendan infusion may induce myocardial ischemia in patients with acute heart failure.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure III: Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Cardiac Catheterization IV: Nursing Management
